CVS – Aetna: The Power of Strategic Competitive Analysis

Posted by Robert Flynn on Oct 27, 2017 2:46:39 PM

The Wall Street Journal and other sources revealed yesterday that pharmacy operator CVS Health Corporation has made an offer to acquire No. 3 health insurer Aetna Inc.  Wouldn’t it have been rewarding to have known the probability of such an acquisition?  Wouldn’t executives of Walgreens and Express Scripts or United Health Group and Anthem have benefited from an evaluation that showed the rationale for such an acquisition? Fuld + Company analysis produced in June 2017 did precisely that. Anticipating just such a move four months ago demonstrates of the power of competitive strategy.

Read More

Topics: Competitive Intelligence, War Games, Early Warning Monitoring, Healthcare, Competitive Strategy

Upcoming Event: Robert Flynn Speaking at Pharma CI US Conference & Exhibition September 14th

Posted by Fuld + Company on Aug 23, 2016 9:19:47 AM

Join us this month at the Pharma CI Conference & Exhibition taking place September 13th - 14th at the Hilton Parsippany in Parsippany, New Jersey.

The Pharma CI Conference & Exhibition is the largest assembly of senior level pharmaceutical, biotech, and medical device professionals seeking the latest news and the chance to network with all the industry’s luminaries.

Members of our Life Sciences team will be at our booth to find out how we can address your competitive intelligence and strategy development needs in the pharmaceutical, biotech, medical device, and diagnostics industries. Robert Flynn, Principal, Strategic Accounts, will be giving a talk on early warning through scenario planning on Wednesday, September 14th.

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Fuld + Company, Pharma, Scenario Analysis

New White Paper: Navigating Risks in Emerging Economies

Posted by Fuld + Company on Feb 19, 2016 10:53:04 AM

Emerging markets present unique competitive challenges. While companies may account for obvious obstacles such as institutional voids and evolving infrastructure, they can fall victim to subtle cultural differences by neglecting to complete on-the-ground research prior to expansion. Local competition knows the rules of the game better than even the most savvy international firm.

Packed with exemplary successes and cautionary tales, our newest white paper - authored by Nathaniel Emmons, Director, Diversified practice - lays out the need for a systematic approach when entering frontier economies. Based on insights from security experts and seasoned investors, the paper offers a four part framework for identifying, analyzing, and reacting to risks and includes an Overseas Expansion Checklist.

To add real-world applicability, the paper focuses on bureaucratic hurdles, political risks, and security issues in diverse African and Asian countries:

Read More

Topics: Competitive Intelligence, Consumer Goods, Early Warning Monitoring, Manufacturing/Industrial, Market Analysis, New Market Entry, Scenario Analysis, Travel/Hospitality, Competitive Strategy

New Video! Companion Diagnostics

Posted by Fuld + Company on Dec 11, 2015 8:00:00 AM

Companion diagnostic (CDx) devices are in vitro and imaging tools that are paired with specific drug therapies. Part of a larger trend towards personalized medicine, they are used to identify patients most likely to benefit from a specific therapeutic agent or to determine appropriate dosage. 

While questions remain about who should bear the cost for companion diagnostics, the promise of greater safety and efficacy and the potential for faster regulatory approval have made this an area of growth for both pharmaceutical and molecular diagnostics clients.

David Staknis, Principal, Practice Head Global Life Sciences, and Ken Sawka, CEO + President, discuss increased requests for monitoring development and expansion of CDx platforms, earlier coordination by pharmaceutical and diagnostics firms, and the benefits of CI for optimizing R&D spending.

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Medical Devices, Pharma, Healthcare, Life Sciences

New Video! Business Disruption

Posted by Fuld + Company on Nov 5, 2015 1:22:38 PM

The latest wave of disruption has been driven by technology platforms, consumer experience, and the oft-cited "sharing economy."

CEO and President Ken Sawka and Founder Leonard Fuld discuss:

  • Is any market safe?
  • Are incumbents reacting in strategic ways?
  • What's the degree of customer stickiness for the likes of Uber and Airbnb? 

Video after the jump.

 

Read More

Topics: Competitive Intelligence, Brand Insights, Early Warning Monitoring, Fuld + Company, Fuld, Leonard, Competitive Strategy

New White Paper! Competitor Crazy Ivans

Posted by Fuld + Company on Nov 5, 2015 1:17:41 PM

What do soviet submarines, Sean Connery, and competitive intelligence have in common?

Our latest white paper Competitor Crazy Ivans reveals the connection.

 

 

Read More

Topics: Early Warning Monitoring, Fuld + Company, Competitive Strategy

Three Approaches to a Defined Strategy Roadmap

Posted by Alexis Kuchins on Jun 17, 2015 2:02:00 PM

A few weeks ago, I attended the Association for Strategic Planning (ASP) annual conference in Tysons Corner, VA. As this was my first entrée into the organization, I was excited to increase my strategy knowledge and skills, and take advantage of the various presentations. From the keynote speakers to the individual breakout sessions one thing was clear: without a defined strategy roadmap, one’s strategy is destined for a less then optimal outcome.

So how do you know if your strategy is on the path to success? Below are three paths to drive your business toward executing a highly impactful strategy.

Read More

Topics: Competitive Intelligence, Product Roadmap, Sales Force Effectiveness, Value Chain Analysis, War Games, Win/Loss/Bid Support, Events, Early Warning Monitoring, Innovation, Market Analysis, New Market Entry, Scenario Analysis, Life Cycle Management, Product Positioning

Healthcare dichotomies that are threatening your industry

Posted by Fuld + Company on Apr 15, 2015 12:00:00 PM

There is a wide gap between what healthcare providers need to do, and what they are actually doing. In many cases they know where they need to go, but not how to get there. Here, we address four of the most critical of these dichotomies, and Fuld + Company's perspective on what needs to be done.

Read More

Topics: Product Roadmap, Early Warning Monitoring, Healthcare

Victory, One Slice at a Time

Posted by Leonard Fuld on Jan 13, 2015 10:00:00 AM

An interview and discussion with David Norton, former CMO of Harrah's and Caesars casinos

Read a story about the CMO of one of the world's largest casinos and how he won back a piece of a very competitive market during difficult times. See how David Norton discarded much of the same-old, same-old way of competing in favor of analytics.

C-Suite executives like to think “big.” But what if big is not the solution? What if the blockbuster drug, the industry-shaping iPhone is not a reality for you, your company and its circumstances? What if the market turns, trashing your payday plans? That is when you need to think incrementally, according to David Norton, former CMO of Harrah’s and Caesars casinos.

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Market Analysis

Are Short CEO Tenures the Reason Companies Don't See Industry Disruptions Coming?

Posted by Leonard Fuld on Dec 2, 2014 10:00:00 AM

Organizations are not allowing CEOs to fulfill a big part of their mission: To help their firms avoid major long-term disruptions and potentially catastrophic failure. The key to fixing this problem is to ensure CEOs integrate the long-term plan into everyday operations, as well as give CEOs a long-enough tenure to execute their plans.

As it stands today, why should CEOs in many instances with an average tenure of half dozen years spend their time on multi-decade challenges that far exceed their stewardship?

Read More

Topics: Competitive Intelligence, Early Warning Monitoring, Scenario Analysis

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.